Call For Applications: February 2021 


Nominations Solicited for 2021 Alvin R. Tarlov & John E. Ware Jr. Doctoral Dissertation and Post- Doctoral Awards in Patient-Reported Outcomes

Application Due Date: Friday, May 28, 2021

The Board of Directors of the Health Assessment Laboratory (HAL) is pleased to announce a second cycle for
the solicitation of applications for the 2021-2022 cycle of the Alvin R. Tarlov & John E. Ware Jr. Doctoral
Dissertation and Post-Doctoral Awards in Patient Reported Outcomes. The purpose of these awards is to
encourage doctoral dissertations and post-doctoral research using patient reported outcomes. We envision up to
two (2) total awards being given for the 2021-22 academic year, with each award being for $25,000 ($20,000
made in September 2021, and an additional $5,000 upon receipt of a satisfactory progress report submitted at
the end of your academic year and no later than July 1, 2022). Eligibility for the 2021-22 academic year is
limited to U.S. citizens enrolled in U.S. based doctoral programs or post-doctoral fellowships in U.S. research

This award is named in honor of the Health Assessment Laboratory's founders, Dr. Alvin Tarlov and Dr. John
Ware, Jr. - two of the world's leading pioneers in the development and use of patient reported outcome
measures. The Health Assessment Lab is a freestanding not-for-profit organization with the goal of advancing
state-of-the-art tools for monitoring health care services and health outcomes from the patient/consumer point
of view. Historically it has had four missions: development and validation of new measures; translation and
adaptation of tools for use in international research; technical assistance in support of patient-based tools in a
variety of specific applications; and education and training in psychometrics as applied to the health care field.
The Selection Committee for 2021-22 is chaired by Professor Eugene Nelson, DSc, a HAL Board Member,
Director of the Population Health Measurement Program at The Dartmouth Institute for Health Policy and
Clinical Practice, and Professor of Community and Family Medicine at Geisel School of Medicine at
Dartmouth College. Other members of the selection committee include: Shelly Greenfield, MD (University of
California, Irvine), Lewis Kazis, ScD (Boston University), Sherry Kaplan, PhD (University of California,
Irvine), Susan Yount, PhD (Northwestern University), and Lisa Zubkoff, PhD (VA and University of Alabama
at Birmingham). Members of the selection committee will be required to recuse themselves from discussions
and votes on any applicants from their home institution or any affiliated entities.

Fundable proposals will be dissertations or post-doctoral research projects that use patient-reported outcomes
(PROs) as a dependent variable. Patient reported outcome measures that will be considered include: (a) PROMs:
patient reported outcome measures related to symptoms, health status and health related quality of life, and (b)
PREMs: patient reported experience measures related to a patient’s experiences in seeking healthcare or in using
healthcare services such as access, communication, caring and concern, patient-clinician relationship, shared
decision-making, engagement in care planning, continuity, etc.
Requirements for Applicants:
1. Doctoral dissertation applicants must either a) defend their dissertation proposal prior to the submission of the application, or b) have the proposal defense scheduled, and include the date of the proposal defense in the applicant’s cover letter and confirmation of the scheduled proposal defense in the dissertation advisor’s letter of recommendation.
2. All proposed work must be completed within 12 months of receiving the initial funding.

Documents required for 2020-21 applications:

1. Cover letter including a brief description of yourself and your project, as well as:
a. Name of degree-granting institution and program, including contact information
b. Name and contact information of dissertation advisor
2. CV (including school email address, personal email address, and other contact information)
3. Two recommendations (including one from dissertation advisor)
4. 8-10 page narrative (excluding appendices) on the dissertation, including the:
a. Title
b. Overall aims of proposed work
c. Specific research questions
d. Conceptual framework or model
e. Proposed methods for work
f. Importance or implications of using patient reported outcomes (as a dependent variable)
g. Proposal/project timeline or Gantt chart to demonstrate the proposed work will be completed within 12 months of the start of funding.

The application should be on standard paper size (8.5” x 11”). Use at least one-half inch margins (top, bottom,
left, and right) for all pages. Use an Arial or Helvetica typeface and a font size of 11 or 12 points. The text of the
application should be single-spaced. Use headings and sub-headings to separate sections and label tables and
Questions regarding the application process or content can be sent to or visit
the HAL website at

Application due date: Friday, May 28, 2021

(before midnight Eastern Standard Time).


Please submit the application
via email to

Dr. Eugene Nelson, Chair, Selection Committee, and Member, Board of Directors, Health Assessment
Laboratory, Dr. Lisa Zubkoff, President, Board of Directors, Health Assessment Laboratory, Inc.

© 2021 Health Assessment Lab